HEIDI PARKER: Open Payments
NPI 1922632975 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,635 in 119 payments from 23 companies in 2025. Trend: 2023 $1,530 · 2024 $1,730 · 2025 $2,635
Food & beverage: $2,535Education: $100
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $628 |
| GlaxoSmithKline, LLC. | 26 | $354 |
| Regeneron Healthcare Solutions, Inc. | 14 | $251 |
| Grifols USA, LLC | 5 | $219 |
| GENZYME CORPORATION | 16 | $205 |
| Axsome Therapeutics, Inc. | 6 | $175 |
| Verona Pharma, Inc. | 10 | $145 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| Electromed, Inc. | 10 | $99 |
| Merck Sharp & Dohme LLC | 4 | $90 |
Products named: DUPIXENT, FASENRA, NUCALA, Prolastin-C Liquid, BREZTRI, Sunosi, Ohtuvayre, TRELEGY ELLIPTA.
Industry payments across AZ — which companies pay providers there.
